Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1

Oncotarget. 2019 Nov 26;10(63):6842. doi: 10.18632/oncotarget.27309.

Kazumasa Sekihara^{1

2}, Kaori Saitoh¹, Lina Han³, Stefan Ciurea³, Shinichi Yamamoto^{1

2}, Mika Kikkawa⁴, Saiko Kazuno⁴, Hikari Taka⁴, Naoko Kaga⁴, Hajime Arai⁴, Takashi Miida¹, Michael Andreeff³, Marina Konopleva³, Yoko Tabe^{1

3

5}

¹ Department of Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
² Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
³ Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁴ Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
⁵ Department of Next Genertion Hematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.16602.].